3. Tarbox M, Walker K, Tan M. Scabies. JAMA 2018;320:612.
6. Sunderkötter C, Feldmeier H, Fölster-Holst R, et al. S1 guidelines on the diagnosis and treatment of scabies: short version. J Dtsch Dermatol Ges 2016;14:1155-1167.
7. Schultz MW, Gomez M, Hansen RC, et al. Comparative study of 5% permethrin cream and 1% lindane lotion for the treatment of scabies. Arch Dermatol 1990;126:167-170.
8. Park J, Kwon SH, Lee YB, Kim HS, Jeon JH, Choi GS. Clinical practice guidelines for the diagnosis and treatment of scabies in Korea: part 2. treatment and prevention. Korean J Dermatol 2023;61:463-471.
10. Kazeminejad A, Hajheydari Z, Ghahari MJ. Scabies treatment in children: a narrative review. J Pediatr Rev 2019;7:105-112.
11. Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep 2021;70:1-187.
12. Executive Committee of Guideline for the Diagnosis and Treatment of Scabies. Guideline for the diagnosis and treatment of scabies in Japan (third edition): Executive Committee of Guideline for the Diagnosis and Treatment of Scabies. J Dermatol 2017;44:991-1014.
14. Thadanipon K, Anothaisintawee T, Rattanasiri S, Thakkinstian A, Attia J. Efficacy and safety of antiscabietic agents: a systematic review and network meta-analysis of randomized controlled trials. J Am Acad Dermatol 2019;80:1435-1444.
15. Jannic A, Bernigaud C, Brenaut E, Chosidow O. Scabies itch. Dermatol Clin 2018;36:301-308.
16. Meinking TL, Taplin D, Hermida JL, Pardo R, Kerdel FA. The treatment of scabies with ivermectin. N Engl J Med 1995;333:26-30.
19. Jacobson CC, Abel EA. Parasitic infestations. J Am Acad Dermatol 2007;56:1026-1043.